Is There Still Value In Risky Assets?

The Carmignac Patrimoine Approach

Published on
June 1, 2026
Read time
5 minute(s) read

Markets are currently navigating a paradox. Interest rates are back close to post-Covid highs, geopolitical risks remain unresolved, and inflationary pressures are resurfacing. Yet equity and credit assets have continued to prove resilient, largely supported by corporate earnings; a theme we explored in our article the price of resilience.

For investors, this raises a central question: should a fund like Carmignac Patrimoine still be exposed to risky assets? We believe the answer is yes but not all of them. In other words, the question is not whether to take risk. It is which risks are still worth taking.

This is especially true as the traditional definition of “risky assets” has become less clear-cut. Gold, usually seen as a safe-haven asset, has behaved more like a momentum asset, while rates have at times been a source of volatility rather than protection. For the purpose of this article, we focus on three areas where risk-taking remains central to portfolio construction: equities, credit and emerging markets debt.

Equity - our preferred growth engine

On equities, we remain globally constructive. It is true that valuations are no longer cheap: US indices are close to all-time highs, leadership has become narrower, and short-term volatility remains unstable against a still uncertain geopolitical backdrop. The elephant in the room for valuations is, of course, the strong move in rates. Higher yields raise the discount rate applied to future earnings and make valuation discipline even more important, particularly in the most expensive parts of the market. But rates alone are not enough for now to justify stepping away from equities when fundamentals continue to deliver. In the US in particular, corporate earnings have been remarkably resilient, with first-quarter profits for S&P 500 companies surprising well above expectations. This earnings momentum is one of the key reasons why equities have been able to absorb higher rates, inflation concerns and geopolitical noise.

That said, the market is becoming more selective. What has worked recently is clear: US exposure, Artificial intelligence (AI) exposure and momentum. At the same time, participation has weakened, with only a small number of stocks driving index performance. This is not necessarily a sign of irrational exuberance; it also shows that investors are increasingly discriminating between companies that can deliver earnings and those that cannot.

Our long-term conviction on AI remains intact. We see it not simply as a market narrative, but as a structural shift in capital allocation, with technology representing a growing share of global investment. However, being positive on AI does not mean being indiscriminately exposed to the whole technology sector. After a strong rally, we have taken regular and incremental profits on parts of our semiconductor exposure, especially in higher-beta names. This is not a change in our long-term view, but a disciplined way to manage valuation risk and portfolio concentration.

At the same time, we have been reinforcing the rest of the equity portfolio. The market’s focus on AI has left other areas neglected, creating opportunities in companies with solid fundamentals and more reasonable valuations. This is why we continue to build a more balanced equity exposure, combining long-term growth themes with diversifiers such as defensive US healthcare distributors, Berkshire Hathaway, and selected Emerging Market banks.

In practice, our approach is a barbell: staying exposed to the structural winners, while adding resilient and attractively valued businesses outside the most crowded parts of the market. We also use put options when market complacency appears excessive and the cost of protection becomes attractive. These out-of-the-money options are designed to protect the portfolio in the event of a significant market shock. In other words, we have a hierarchy of probabilities, but we build the portfolio to survive being wrong. We are therefore positive on equities, but the message is clear: with rates having moved sharply, valuation discipline is central to portfolio construction.

Credit - selective carry, no broad beta

After two years of strong performance, credit has been one of the most rewarding areas of fixed income, largely because carry proved far more effective than long-duration government bonds. However, the strong demand for yield has also pushed valuations higher, leaving less margin for error.

Credit markets have shown solid resilience during recent episodes of volatility, including the stress that followed “Liberation Day”1. Yet this resilience should not be confused with the absence of risk. We believe the new protectionist environment, persistent supply-chain disruptions and the risk of higher-for-longer inflation could put pressure on more vulnerable issuers, especially in sectors such as consumer goods, autos, chemicals and export-driven industries. At the same time, a higher cost of capital increases refinancing risk and should contribute to a gradual normalisation of default rates.

This is why we do not believe the best opportunity today lies in broad credit beta. In a multi-asset portfolio, we would rather take directional risk through equities, where upside participation is more compelling, than through generic credit exposure, where spreads already reflect a significant amount of optimism.

That said, credit remains a deep and inefficient market, which creates opportunities for active investors. The key is to focus on areas where carry is supported by fundamentals. We continue to see value in selected high-yield bonds, particularly in energy, where companies have rationalised their business models after years of underinvestment and can also benefit from heightened geopolitical tensions, as recently illustrated by renewed concerns around the Strait of Hormuz, and in financial debt, especially European banks, whose balance sheets have been structurally strengthened by post-2008 regulation. Structured credit can also offer attractive risk-adjusted opportunities when carefully selected.

Given the current valuation backdrop, hedging remains essential. A strategy combining idiosyncratic credit selection with protection through credit indices or CDS can help preserve carry while limiting exposure to a broader spread-widening episode. CDS positions hedge credit risk directly, but they also provide broader protection against a deterioration in risk sentiment across markets, including equities, making them an efficient way to protect multi-asset portfolios against a wider risk-off episode.

EM debt & currencies - the spicy diversifier

Emerging markets entered 2026 from a position of strength, supported by higher real rates, stronger external balances and more credible policy frameworks. The volatility triggered by the March oil shock did not lead to broader financial stress, highlighting the improved resilience of the asset class versus previous crisis episodes.

The case for EM debt remains supported by attractive carry, improving fundamentals, lower US real yields and a softer dollar. However, valuations are no longer uniformly cheap, meaning investors need to focus less on broad beta exposure and more on country, currency and credit selection. Opportunities such as Mexican debt or selected African sovereigns, including Ivory Coast, illustrate how value can still be found.

FX appear to be most compelling opportunities, and we continue to favour currencies where carry, valuation and external dynamics offer, for us, the best asymmetry. Latin America remains a core area of conviction, with the Brazilian real and Chilean peso standing out thanks to attractive carry, deep liquidity and supportive macro frameworks. That said, we remain cautious on local rates, as elevated oil prices and renewed inflation pressures could force some central banks to pause easing cycles or even resume hikes.

Carmignac Patrimoine positioning

Building a diversified portfolio such as Carmignac Patrimoine therefore means allocating capital where the risk-reward profile appears most compelling. This requires a clear view on risk assets, but also a broader portfolio construction discipline to avoid simply accumulating correlated risks.

In this context, and given that the equity-bond correlation is more positive than in the past, our exposure to the risk assets discussed above must be balanced with complementary portfolio levers. For example, maintaining a low, or even negative, modified duration in the United States can help offset the risk of renewed upward pressure on yields and provide a more robust overall portfolio structure.

Ultimately, the objective is not only to identify attractive investment opportunities, but to combine them in a way that preserves diversification, mitigate drawdowns and improves the portfolio’s ability to perform.

Source: Carmignac, Bloomberg, 29/05/2026.
102/04/2025.

Carmignac Patrimoine

A turnkey global solution to face various market conditions

Carmignac Patrimoine A EUR Acc

ISIN: FR0010135103
Recommended minimum investment horizon
3 years
Risk indicator*
3/7
SFDR - Fund Classification**
Article 8

*Risk Scale from the KID (Key Information Document). Risk 1 does not mean a risk-free investment. This indicator may change over time. **Sustainable Finance Disclosure Regulation (SFDR) 2019/2088. The SFDR classification of the Funds may change over time.

Main risks of the fund

Equity: The Fund may be affected by stock price variations, the scale of which is dependent on external factors, stock trading volumes or market capitalization.
Interest Rate: Interest rate risk results in a decline in the net asset value in the event of changes in interest rates.
Credit: Credit risk is the risk that the issuer may default.
Currency: Currency risk is linked to exposure to a currency other than the Fund’s valuation currency, either through direct investment or the use of forward financial instruments.
The Fund presents a risk of loss of capital.

Fees

ISIN: FR0010135103
Entry costs
4,00% of the amount you pay in when entering this investment. This is the most you will be charged. Carmignac Gestion doesn't charge any entry fee. The person selling you the product will inform you of the actual charge.
Exit costs
We do not charge an exit fee for this product.
Management fees and other administrative or operating costs
1,80% of the value of your investment per year. This estimate is based on actual costs over the past year.
Performance fees
20,00% max. of the outperformance once performance since the start of the year exceeds that of the reference indicator and if no past underperformance still needs to be offset. The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years, or since the product creation if it is less than 5 years.
Transaction Cost
0,32% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the investments underlying the product. The actual amount varies depending on the quantity we buy and sell.

Performance

ISIN: FR0010135103
Carmignac Patrimoine+3,2+12,1+7,1+2,2−9,4−0,9+12,4+10,5−11,3+0,1
Reference Indicator+2,7+1,1+11,4+7,7−10,3+13,3+5,2+18,2−0,1+1,5
Carmignac Patrimoine+8,2%+2,0%+2,8%
Reference Indicator+6,9%+4,1%+5,6%

Source: Carmignac at Apr 30, 2026.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.

Reference Indicator: 40% MSCI AC World NR index + 40% ICE BofA Global Government index + 20% €STR Capitalized index. Quarterly rebalanced.

Marketing communication. Please refer to the KID/KIID, prospectus of the fund before making any final investment decisions.

This material may not be reproduced, in whole or in part, without prior authorisation from the Management Company. This material does not constitute a subscription offer, nor does it constitute investment advice. This material is not intended to provide, and should not be relied on for, accounting, legal or tax advice. This material has been provided to you for informational purposes only and may not be relied upon by you in evaluating the merits of investing in any securities or interests referred to herein or for any other purposes. The information contained in this material may be partial information and may be modified without prior notice. They are expressed as of the date of writing and are derived from proprietary and non-proprietary sources deemed by Carmignac to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by Carmignac, its officers, employees or agents.

Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.

Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.

Morningstar Rating™ : © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Access to the Funds may be subject to restrictions regarding certain persons or countries. This material is not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the material or availability of this material is prohibited. Persons in respect of whom such prohibitions apply must not access this material. Taxation depends on the situation of the individual. The Funds are not registered for retail distribution in Asia, in Japan, in North America, nor are they registered in South America. Carmignac Funds are registered in Singapore as restricted foreign scheme (for professional clients only). The Funds have not been registered under the US Securities Act of 1933. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a «U.S. person», according to the definition of the US Regulation S and FATCA.
The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital.

The Funds’ prospectus, KIDs, NAVs and annual reports are available at www.carmignac.com/en, or upon request to the Management Carmignac Portfolio refers to the sub-funds of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive. The French investment funds (fonds communs de placement or FCP) are common funds in contractual form conforming to the UCITS or AIFM Directive under French law.

  • In the United Kingdom: the Funds’ respective prospectuses, KIIDs and annual reports are available at www.carmignac.com/en-gb, or upon request to the Management Company, or for the French Funds, at the offices of the acilities Agent, Carmignac UK Ltd, 2 Carlton House Terrace, London, SW1Y 5AF. This document was prepared by Carmignac Gestion, Carmignac Gestion Luxembourg or Carmignac UK Ltd. FP Carmignac ICVC (the “Company”) is an Investment Company with variable capital incorporated in England and Wales under registered number 839620 and is authorised by the FCA with effect from 4 April 2019 and launched on 15 May 2019. FundRock Partners Limited is the Authorised Corporate Director (the “ACD”) of the Company and is authorised and regulated by the FCA. Registered Office: Hamilton Centre, Rodney Way, Chelmsford, Essex, CM1 3BY, UK; Registered in England and Wales with number 4162989. Carmignac Gestion Luxembourg SA has been appointed as the Investment Manager and distributor in respect of the Company. Carmignac UK Ltd (Registered in England and Wales with number 14162894) has been appointed as a sub-Investment Manager of the Company and is authorised and regulated by the Financial Conduct Authority with FRN:984288.

  • In Switzerland: the prospectus, KIDs and annual report are available at www.carmignac.com/en-ch, or through our representative in Switzerland, CACEIS (Switzerland), S.A., Route de Signy 35, CH-1260 Nyon. The paying agent is CACEIS Bank, Montrouge, Nyon Branch / Switzerland, Route de Signy 35, 1260 Nyon.

The Management Company can cease promotion in your country anytime. Investors have access to a summary of their rights in English on the following links: UK ; Switzerland ; France ; Luxembourg ; Sweden.

For Carmignac Portfolio Long-Short European Equities: Carmignac Gestion Luxembourg SA in its capacity as the Management Company for Carmignac Portfolio, has delegated the investment management of this Sub-Fund to White Creek Capital LLP (Registered in England and Wales with number OCC447169) from 2nd May 2024. White Creek Capital LLP is authorised and regulated by the Financial Conduct Authority with FRN : 998349.

Carmignac Private Evergreen refers to the Private Evergreen sub-fund of the SICAV Carmignac S.A. SICAV – PART II UCI, registered with the Luxembourg RCS under number B285278.